Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (351-360 of 401) with videos related to

Pageof 41
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|April 8, 2026
Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European CohortsJosefin Sundh, William A E Parker, Jonas Oldgren, et al.
Journal of the American College of Cardiology|February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trialKenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
European Heart Journal|October 23, 2015
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54Marc P Bonaca, Deepak L Bhatt, P Gabriel Steg, et al.
Thrombosis and Haemostasis|March 9, 2016
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
American Heart Journal|February 9, 2018
Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC studyAkshay Bagai, Shaun G Goodman, Warren J Cantor, et al.
European Heart Journal|March 7, 2018
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on ThrombosisBianca Rocca, Keith A A Fox, Ramzi A Ajjan, et al.
BMJ Open|May 9, 2025
Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional studyWilliam A E Parker, Josefin Sundh, Jonas Oldgren, et al.
European Heart Journal. Acute Cardiovascular Care|August 26, 2017
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC TrialEnrico Fabris, Arnoud van 't Hof, Christian W Hamm, et al.
European Heart Journal|September 11, 2019
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesJuhani Knuuti, William Wijns, Antti Saraste, et al.
Journal of the American College of Cardiology|February 7, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary DiseaseSameer Bansilal, Marc P Bonaca, Jan H Cornel, et al.
Pageof 41

Showing results (351-360 of 401) with videos related to

Sort By:
Pageof 41
International Journal of Chronic Obstructive Pulmonary Disease|April 8, 2026
Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European CohortsJosefin Sundh, William A E Parker, Jonas Oldgren, et al.
Journal of the American College of Cardiology|February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trialKenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
European Heart Journal|October 23, 2015
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54Marc P Bonaca, Deepak L Bhatt, P Gabriel Steg, et al.
Thrombosis and Haemostasis|March 9, 2016
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart DiseaseRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
American Heart Journal|February 9, 2018
Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC studyAkshay Bagai, Shaun G Goodman, Warren J Cantor, et al.
European Heart Journal|March 7, 2018
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on ThrombosisBianca Rocca, Keith A A Fox, Ramzi A Ajjan, et al.
BMJ Open|May 9, 2025
Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional studyWilliam A E Parker, Josefin Sundh, Jonas Oldgren, et al.
European Heart Journal. Acute Cardiovascular Care|August 26, 2017
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC TrialEnrico Fabris, Arnoud van 't Hof, Christian W Hamm, et al.
European Heart Journal|September 11, 2019
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesJuhani Knuuti, William Wijns, Antti Saraste, et al.
Journal of the American College of Cardiology|February 7, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary DiseaseSameer Bansilal, Marc P Bonaca, Jan H Cornel, et al.
Pageof 41